CV Sciences, Inc. (OTCPK:CVSI) is looking for acquisitions. Joseph Dowling, Chief Executive Officer said, "We are continuing to evaluate both inbound and outbound M&A opportunities and have seen a significant increase in acquisition opportunities. We will be selective, but adding revenue by acquisition is a viable strategy for us.
We are also looking at other new domestic opportunities and selected international opportunities that will allow us to leverage our brand, infrastructure, trust in our company and the strength of our employees".
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). It also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands, such as +PlusCBD and Cultured Foods in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its +PlusCBD branded products are sold at select retail locations throughout the United States. The Company's Cultured Foods brand provides a variety of 100% plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience.
CV SCIENCES, INC. 
